S9 Ep19: Trent Breaks Down Mutation Testing and ctDNA Monitoring in GIST

Dr Trent discusses the need for improved awareness around mutation testing in GIST, the limitations of current clinical trial criteria, and the potential for ctDNA to become a longitudinal cancer monitoring tool, helping to prevent invasive means of measuring disease progression.